Tesseract Medical Research - MuSolve SR, 90 capsules

MuSolve SR by Tesseract Medical Research is a dietary supplement designed to support joint health and mobility. The product comes in a bottle containing 90 capsules. Each capsule incorporates a patented ingredient delivery system that features sustained-release technology. This technology ensures a consistent release of active ingredients over an extended period.

MuSolve SR contains Boswellia serrata extract, a botanical compound known for its potential to support normal inflammatory responses and joint function. The extract is standardized to contain Boswellic acids, aimed at maintaining joint health.

The supplement's formulation is free from gluten, soy, and dairy, making it suitable for individuals with specific dietary restrictions. It is also non-GMO to align with the preferences of health-conscious consumers.

Suggested use involves taking three capsules daily, preferably with food. This dosage is intended for adults, and it is recommended to consult a healthcare professional before incorporating this supplement into your routine, especially if you are pregnant, nursing, taking medication, or have a medical condition.

Each serving size of three capsules provides a specific amount of Boswellia serrata extract to aid in joint support. The product is manufactured in a facility that follows Good Manufacturing Practices (GMP), ensuring quality and purity.

MuSolve SR is intended to be a part of a balanced approach to joint health, complementing other lifestyle and dietary measures aimed at maintaining physical well-being. This product is not intended to diagnose, treat, cure, or prevent any disease. Always read the label and use as directed.

All orders are shipped within 24 hours, via next day delivery using Royal Mail Tracked shipping.

If for any reason you are not satisfied with your order we offer a 30 day return policy. The item you return must be sent in the same condition as received, and inside the original packaging. Once received we will notify you via email.